Author: Ebbert Jon O. Hays J. Taylor Hurt Richard D.
Publisher: Adis International
ISSN: 0012-6667
Source: Drugs, Vol.70, Iss.6, 2010-04, pp. : 643-650
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Second Generation of COX-2 Inhibitors: What Advantages Do the Newest Offer?
By Stichtenoth D.O. Frölich J.C.
Drugs, Vol. 63, Iss. 1, 2003-01 ,pp. :
Aldosterone Receptor Antagonists for Hypertension: What Do They Offer?
Drugs, Vol. 63, Iss. 19, 2003-01 ,pp. :
What does istradefylline have to `off'er in PD?
Inpharma, Vol. 1, Iss. 1409, 2003-01 ,pp. :
Organised Management Teams for Stroke: What Are They and What Are Their Advantages?
By Spriggs D.
CNS Drugs, Vol. 10, Iss. 6, 1998-12 ,pp. :